They write because BPC-157 has not been extensively studied in humans, no one knows if there is a safe dose, or if there is any way to use this compound safely to treat specific medical conditions. Furthermore, USADA highlights that BPC 157 is not approved for human use as a drug, and there's a notable lack of published clinical trial data
Momentous Huberman Stack, Acetyl-Carnitine
53,73 The disulfide bond reduction and irreparable trimming of N -linked glycans generate degrons selectively modified with glycans such as Man 7 GlcNAc 2 , Man 6 GlcNAc 2 , or Man 5 GlcNAc 2 , which prevents substrate re-engagement with calnexin or calreticulin for nonproductive folding cycles
The invention has the advantages of stable quality, controllability and safety
Drug Res 71 , 122137 (2021)